Elon Musk sues OpenAI and Sam Altman over ‘betrayal’ of non-profit AI mission

Elon Musk sued OpenAI, its co-founders Sam Altman and Greg Brockman and affiliated entities on Thursday, alleging they breached their original contractual agreements by pursuing profits instead of the nonprofit’s founding mission to develop AI that benefits humanity.

Musk, an early backer of OpenAI, claims Altman and Brockman convinced him to help found and bankroll the startup in 2015 with promises it would be a non-profit focused on countering the competitive threat from Google. Musk alleges OpenAI has shifted to a for-profit model focused on commercializing its AGI research with Microsoft, the world’s most valuable company.

The lawsuit, filed in a court in San Francisco, centers around OpenAI’s latest natural language model, GPT-4, which Musk claims constitutes AGI. He alleges OpenAI and Microsoft have improperly licensed GPT-4 despite agreeing OpenAI’s AGI capabilities would remain non-profit and dedicated to humanity.

Musk is seeking to compel OpenAI to adhere to its original mission and bar from monetizing technologies developed under its non-profit for the benefit of OpenAI executives or partners like Microsoft. The suit also requests the court rule AI systems like GPT-4 and other advanced models in development constitute artificial general intelligence that reaches beyond licensing agreements. In addition to injunctions forcing OpenAI’s hand, Musk asks for accounting and potential restitution of donations meant to fund its public-minded research should the court find it now operates for private gain.

“Mr. Altman hand-picked a new Board that lacks similar technical expertise or any substantial background in AI governance, which the previous board had by design. Mr. D’Angelo, a tech CEO and entrepreneur, was the only member of the previous board to remain after Mr. Altman’s return. The new Board consisted of members with more experience in profit-centric enterprises or politics than in AI ethics and governance,” the lawsuit adds.

This is a developing story. Check back for updates. 

Leave a Reply

Your email address will not be published. Required fields are marked *